Mozart Therapeutics
Rachel Keylin is an experienced professional currently serving as an Executive Assistant at Mozart Therapeutics, Inc. since October 2022. Prior to this role, Rachel Keylin held several positions at Neoleukin Therapeutics, including Senior People Team Coordinator, where responsibilities included managing onboarding and offboarding processes, and serving as the primary point of contact for employee benefits and payroll inquiries. Additional experience includes roles at Aptevo Therapeutics, Beyondsoft, zulily, and Clear Channel Communications, showcasing a strong background in coordination, administrative support, marketing, and event planning. Rachel Keylin earned a Bachelor of Arts in Communication from Western Washington University in 2014.
This person is not in any teams
Mozart Therapeutics
Mozart Therapeutics is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases. The company is using a novel regulatory CD8 T cell network to create disease-modifying CD8 Treg modulators for a variety of autoimmune diseases. Mozart is developing a pipeline of first-in-class 'CD8Treg modulators with the goal of restoring long-term immune balance and preventing the progressive damage caused by an autoreactive and pathogenic immune response.